BTK Inhibitors in CLL: Summer Data Updates and Expert Perspectives
Listen now
Description
Join 3 expert faculty as they discuss important data on the use of BTK inhibitor therapy presented during the summer 2021 meetings.
Credit available for this activity expires: 8/27/2022
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/957239?src=mkm_podcast_addon_957239
More Episodes
Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer?
Credit available for this activity expires: 4/16/25
Earn Credit / Learning Objectives & Disclosures:...
Published 04/17/24
Who in the care team can detect cognitive impairment and aid in diagnosing early stages of Alzheimer's disease (AD)?
Credit available for this activity expires: 4/10/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000668?ecd=bdc_podcast_libsyn_mscpedu
Published 04/12/24
Published 04/12/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
